fbpx
  • Home
  • Study Details
By physician referral or invitation only

Regulatory T Cells for Treatment of COVID-19 Pneumonia

The purpose of this study is to determine if cellular therapy of regulatory T cells could be used to treat patients with COVID-19 pneumonia.

Age & Gender

  • 18 years ~ 70 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Jason Mock
Medicine-Pulmonary

Study Type

Clinical or Medical
Interventional

Study Topics

COVID-19

IRB Number

21-1577

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.